Media
Videos
PharmAla Biotech signs supply deal with Global Wellness Strategies to provide MDMA for trial
Psychedelics 101 | February 8, 2022
Expert Outlook 2021: Nick Kadysh
Rick Doblin, Exec. Director, MAPS & Nick Kadysh, President & CEO, PharmAla Biotech | MDMA Conference
Media Releases
PharmAla Biotech & SABI Mind Announce MDMA Supply Agreement
Posted: May 19, 2022
PharmAla Biotech Expands MDMA Distribution with CCrest Labs
Posted: May 10, 2022
PharmAla Biotech to supply Mind Medicine Australia with GMP MDMA for Clinical Trial
Posted: Apr. 09, 2022
PharmAla Biotech adds David Purcell as Director of Sales
Posted: Mar. 14, 2022
PharmAla Biotech contracts with InterVivo Solutions to validate novel MDMA analogs
Posted: Mar. 07, 2022
Global Wellness Strategies Signs MDMA Supply Agreement with PharmAla Biotech
Posted: Feb. 10, 2022
PharmAla Biotech initiates research at the University of Arkansas for Medical Sciences
Posted: Jan. 17, 2022
PharmAla Biotech Announces Listing on the Canadian Securities Exchange
Posted: Jan. 10, 2022
Search Releases
Type keywords to filter the list of press releases:
Media Inquiries
Nicholas Kadysh, CEO
press@pharmala.ca